Procedural complication and long term outcomes after alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: data from China

被引:14
|
作者
An, Shuo-yan [1 ,2 ]
Yang, Yin-jian [1 ,2 ]
Hang, Fei [1 ,2 ]
Wang, Zhi-min [2 ,3 ]
Fan, Chao-mei [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Key Lab Clin Trial Res Cardiovasc Drugs, Minist Hlth, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Ultrasound, Beijing, Peoples R China
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
关键词
TASK-FORCE; FOLLOW-UP; MYECTOMY; SURVIVAL; METAANALYSIS; GUIDELINE; DIAGNOSIS; DEATH; YOUNG;
D O I
10.1038/s41598-017-10144-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Data on procedural complications and long term survival after alcohol septal ablation (ASA) in Chinese patients with obstructive hypertrophic cardiomyopathy (HOCM) are lacking. We aimed to investigate long-term survival of HOCM patients after ASA and compared to the non-obstructive hypertrophic cardiomyopathy(NOHCM). A total of 233 patients with HOCM and a peak pressure gradient of >= 50 mm Hg at rest or with provocation were consecutively enrolled from Fuwai Hospital in China between 2000 and 2012. Another 297 patients without left ventricular outflow tract obstruction were regarded as control group. Periprocedural mortality of ASA were low (0.89%). Periprocedural lethal ventricular arrhythmia occurred in 9 patients (4.0%). Alcohol volume (RR 1.44, 95% CI: 1.03-2.03, P = 0.034) and age <= 40 years old (RR 4.63, 95% CI: 1.07-20.0, P = 0.040) were independent predictors for periprocedural lethal ventricular arrhythmia. The 10-year overall survival was 94.6% in the ASA group, similar with 92.9% in the NOHCM group (P = 0.930). In conclusion, periprocedural mortality and complications were rare in ASA. Long term survival after ASA were satisfactory and comparable to NOHCM. Patients under 40 years old should be more cautious undergoing ASA, for these patients were more likely to endure lethal ventricular arrhythmia during periprocedural period of ASA.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Long-Term Survival After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Experience
    Fernandes, Valerian
    Karimianpour, Ahmadreza
    Rier, Jeremy D.
    Shaji, Shawn
    Mullinax, Billy J.
    Wahlquist, Amy H.
    Nielsen, Christopher D.
    JOURNAL OF INVASIVE CARDIOLOGY, 2021, 33 (10) : E769 - E776
  • [32] Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
    Rigopoulos, Angelos G.
    Panou, Fotios
    Kremastinos, Dimitrios Th.
    Seggewiss, Hubert
    HELLENIC JOURNAL OF CARDIOLOGY, 2009, 50 (06) : 511 - 522
  • [33] Ten Tips and Tricks for Performing Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy
    Veselka, Josef
    INTERNATIONAL JOURNAL OF ANGIOLOGY, 2020, 29 (03) : 180 - 182
  • [34] Alcohol septal ablation in hypertrophic cardiomyopathy: For which patients?
    Achim, Alexandru
    Serban, Adela Mihaela
    Mot, Stefan Dan Cezar
    Leibundgut, Gregor
    Marc, Madalin
    Sigwart, Ulrich
    ESC HEART FAILURE, 2023, 10 (03): : 1570 - 1579
  • [35] Is There a Role for Alcohol Septal Ablation in Young Patients with Medically Refractory Hypertrophic Obstructive Cardiomyopathy?
    Sivakumar, Kothandam
    Jain, Gaurav
    PEDIATRIC CARDIOLOGY, 2024, 45 (03) : 648 - 659
  • [36] Long-term Clinical Follow-Up of Patients Undergoing Percutaneous Alcohol Septal Reduction for Symptomatic Obstructive Hypertrophic Cardiomyopathy
    de Cano, Silvia Fortunato
    Cano, Manuel Nicolas
    Costa, Jose de Ribamar, Jr.
    Pinheiro, Jairo Alves, Jr.
    de Mattos Barretto, Rodrigo Bellio
    de Souza Le Bihan, David Costa
    Abizaid, Alexandre
    Sousa, Amanda
    Eduardo Sousa, J.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 88 (06) : 953 - 960
  • [37] Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry
    Veselka, Josef
    Faber, Lothar
    Liebregts, Max
    Cooper, Robert
    Januska, Jaroslav
    Krejci, Jan
    Bartel, Thomas
    Dabrowski, Maciej
    Hansen, Peter Riis
    Almaas, Vibeke Marie
    Seggewiss, Hubert
    Horstkotte, Dieter
    Adlova, Radka
    Bundgaard, Henning
    ten Berg, Jurrien
    Stables, Rodney Hilton
    Jensen, Morten Kvistholm
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (05):
  • [38] How Symptomatic Should a Hypertrophic Obstructive Cardiomyopathy Patient Be to Consider Alcohol Septal Ablation?
    Jones, Brandon M.
    Krishnaswamy, Amar
    Smedira, Nicholas G.
    Desai, Milind Y.
    Tuzcu, E. Murat
    Kapadia, Samir R.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (05):
  • [39] Association between left ventricular reverse remodeling and long-term outcomes after alcohol septal ablation for hypertrophic obstructive cardiomyopathy
    Duan, Fu-Jian
    Chen, You-Zhou
    Yuan, Jian-Song
    Zhang, Yan
    Qiao, Shu-Bin
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2023, 39 (02) : 423 - 432
  • [40] Septal alcohol ablation in hypertrophic obstructive cardiomyopathy: A retrospective analysis
    Yavuzgil, Oguz
    Tuluce, Kamil
    Simsek, Evrim
    Gurgun, Cemil
    Kultursay, Hakan
    Payzin, Serdar
    Hasdemir, Can
    Can, Levent Hurkan
    Turkoglu, Cuneyt
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 20 (03): : 427 - 433